Screener
Immuneering Corporation IMRX Q4 2025 Annual earnings
Reported March 6, 2026 · Before market open
EPS-$0.18Beat by $0.13
EPS estimate-$0.31
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.29
Versus estimates
Diluted EPS
FAQ
- When did Immuneering Corporation report Q4 2025 earnings?
- Immuneering Corporation (IMRX) reported Q4 2025 earnings on March 6, 2026 before market open.
- What were Immuneering Corporation's Q4 2025 revenue and EPS?
- Immuneering Corporation reported eps of $-0.18 for Q4 2025.
- Did Immuneering Corporation beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.31 by $0.13.
- How did Immuneering Corporation's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 69.0% from $-0.58.
- Where can I find Immuneering Corporation's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001790340-26-000040) and the 10-K periodic report (0001790340-26-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.
